Ledger.Open graph →
SEC Form D · filed September 30, 2016

Bolt Biotherapeutics, Inc

Offering
$16.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLEASANTON, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Edgar G. Engleman · Redwood City, CAExec · DirectorReiner Laus · Pleasanton, CAExec · DirectorPeter G. Bisgaard · Pleasanton, CADirectorPeter G. Moldt · Pleasanton, CADirectorMahendra G. Shah · Pleasanton, CADirectorEdgar G. Engleman · Redwood City, CAExec · DirectorReiner Laus · Pleasanton, CAExec · DirectorPeter G. Bisgaard · Pleasanton, CADirectorPeter G. Moldt · Pleasanton, CADirectorMahendra G. Shah · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗